Fortis Healthcare Share Price Today | Stock Price & Fortis Healthcare Share Screener
As of October 23, 2026, the live Fortis Healthcare share price (NSE: FORTIS) is ₹712.90 on NSE and ₹720.00 on BSE, down 1.89% from the previous close, with shares trading between ₹704.95 and ₹728.65 in today's trading session, and a 52-week range of ₹712.90–₹1,057.00. Check FORTIS 52-week performance for the annual price range and momentum. Use the Fortis Healthcare stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Fortis Healthcare opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Over the trailing twelve months the company reported revenue of ₹2,375 and net income of ₹271, with EBITDA of ₹530, an operating margin of 22.0% and a profit margin of 11.4%.
Fortis Healthcare Share Price Chart
Track the current stock price of Fortis Healthcare with an interactive chart. Analyse FORTIS share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Fortis Healthcare stock quote in one place.
The quote of ₹712.90 sits between the 52-week low of ₹712.90 and the 52-week high of ₹1,057.00, and the latest session moved -1.89% from the previous close.
Fortis Healthcare Company Profile - Fundamental Screener
Screen Fortis Healthcare company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for FORTIS shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare Services sector and the Hospitals industry, with Leo Puri listed as chairperson or CEO, and it trades under ISIN INE061F01013.
Business Overview
Fortis Healthcare Limited is one of India's largest healthcare providers, operating 27 hospitals with 4,500 operational beds and over 426 diagnostics centres as of March 31, 2023. The company offers a wide range of integrated healthcare services including cardiac care, orthopedics, neurosciences, oncology, renal care, gastroenterology, and mother and child...more
Company Details
Classification
Identifiers and Leadership
Fortis Healthcare Balance Sheet Screener
Screen FORTIS balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹15,966, up from ₹13,692 in 2025.
Latest statistics put total assets at ₹15,966 and shareholder funds at ₹10,169, with a leverage ratio of 0.32.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
Assets |
||||||||||
| Total Assets | 15,966 | 13,692 | 13,289 | 12,434 | 11,885 | 11,155 | 11,348 | 11,951 | 8,622 | 9,717 |
| Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fixed Assets | 12,230 | 10,424 | 9,874 | 9,426 | 9,416 | 8,799 | 8,802 | 8,477 | 4,992 | 5,419 |
Liabilities |
||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 3,683 | 2,915 | 1,563 | 2,907 | 3,607 | 3,204 | 1,563 | 1,248 | 1,171 | 1,480 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
||||||||||
| Total Equity | 10,169 | 9,169 | 8,556 | 8,100 | 7,008 | 6,718 | 7,206 | 7,113 | 5,317 | 6,311 |
| Share Capital | 755 | 755 | 755 | 755 | 755 | 755 | 755 | 755 | 519 | 518 |
| Reserves & Surplus | 9,141 | 8,162 | 6,908 | 6,487 | 5,423 | 5,365 | 5,906 | 5,846 | 3,543 | 4,626 |
Fortis Healthcare Income Statement Screener - Profit & Revenue Analysis
Screen Fortis Healthcare income statement and profit fundamentals. Analyze FORTIS quarterly results. Fortis Healthcare reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For 2026-Mar, revenue was ₹2,375 and net profit was ₹271, equal to earnings per unit of ₹3.52, at an operating margin of 22%.
In that period expenses were ₹1,845, interest cost ₹84 and tax ₹53. The next period listed, 2026-Jun, shows revenue of ₹2,573 and net profit of ₹273.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | |||||||||||||||
| Revenue | 2,375 | 2,573 | 2,032 | 2,198 | 2,381 | 2,277 | 1,803 | 1,873 | 2,006 | 1,975 | 1,669 | 1,667 | 1,788 | 1,699 | 1,391 |
| Expenses | 1,845 | 2,008 | 1,625 | 1,676 | 1,775 | 1,805 | 1,405 | 1,516 | 1,613 | 1,553 | 1,372 | 1,386 | 1,440 | 1,396 | 1,157 |
Operating Costs and Margins | |||||||||||||||
| EBITDA | 530 | 566 | 406 | 522 | 606 | 472 | 398 | 356 | 393 | 422 | 297 | 282 | 349 | 303 | 234 |
| Operating Profit % | 22.00% | 21.00% | 19.00% | 23.00% | 24.00% | 20.00% | 21.00% | 18.00% | 19.00% | 19.00% | 16.00% | 16.00% | 19.00% | 17.00% | 16.00% |
| Depreciation | 122 | 122 | 102 | 102 | 106 | 120 | 92 | 91 | 95 | 97 | 82 | 79 | 84 | 87 | 77 |
| Interest | 84 | 80 | 68 | 70 | 75 | 86 | 35 | 35 | 36 | 45 | 32 | 32 | 32 | 33 | 30 |
Profit and Earnings | |||||||||||||||
| Profit Before Tax | 324 | 363 | 237 | 351 | 425 | 266 | 271 | 230 | 261 | 279 | 183 | 171 | 233 | 183 | 126 |
| Tax | 53 | 90 | 49 | 84 | 97 | 68 | 68 | 56 | 68 | 25 | 45 | 47 | 49 | 49 | 39 |
| Net Profit | 271 | 273 | 188 | 267 | 329 | 197 | 203 | 174 | 193 | 254 | 138 | 124 | 184 | 134 | 87 |
| EPS | 3.52 | 3.53 | 2.44 | 3.45 | 4.26 | 2.57 | 2.37 | 2.20 | 2.34 | 3.28 | 1.76 | 1.48 | 2.30 | 1.78 | 0.90 |
Fortis Healthcare Cash Flow Screener - Liquidity Fundamentals
Screen FORTIS cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities generated ₹1,601, and net cash flow was an inflow of ₹228.
Over the same period, investing activities used ₹1,537 and financing activities provided ₹164.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations and Investing | ||||||||||
| Operating Activities | 1,601 | 1,424 | 1,100 | 822 | 865 | 486 | 172 | -179 | 493 | 967 |
| Investing Activities | -1,537 | -780 | -889 | -373 | -501 | -131 | 64 | -3,279 | -333 | -1,001 |
Financing and Net Cash | ||||||||||
| Financing Activities | 164 | -714 | -87 | -471 | -517 | -143 | -862 | 4,257 | -672 | 259 |
| Net Cash Flow | 228 | -70 | 125 | -22 | -153 | 212 | -627 | 799 | -513 | 225 |
Fortis Healthcare Shareholding Pattern Screener
See Fortis Healthcare shareholding pattern with promoter, FII, and DII holdings. Check Fortis Healthcare promoter holding and ownership changes for FORTIS on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Mar, promoters held 31.17%, foreign institutions 25.97%, domestic institutions 31.35% and the public 9.96%, spread across 226,685 shareholders.
The shareholder count was 226,685 in 2026-Mar, compared with 220,743 in 2026-Jun.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 31.17% | 31.17% | 31.17% | 31.17% | 31.17% | 31.17% | 31.17% | 31.17% |
Institutional Investors | ||||||||
| FII Holding | 25.97% | 25.20% | 27.40% | 27.17% | 27.90% | 27.84% | 23.24% | 23.31% |
| DII Holding | 31.35% | 32.23% | 29.46% | 29.79% | 29.14% | 29.33% | 31.15% | 32.31% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 9.96% | 9.87% | 10.22% | 10.17% | 10.14% | 10.14% | 10.82% | 10.47% |
| Other Holding | 1.54% | 1.53% | 1.75% | 1.70% | 1.65% | 1.53% | 3.63% | 2.75% |
| Shareholder Count | 226,685 | 220,743 | 218,329 | 205,373 | 220,766 | 233,156 | 157,165 | 154,260 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Fortis Healthcare. Fortis Healthcare dividend yield can be compared with peers and other stocks in the market.
The latest dividend recorded was ₹1.00 per unit for 2026-March, a yield of 0.14%, compared with ₹1.00 for 2025-March.
Dividends are listed for 10 periods, with the three most recent payouts at ₹1.00, ₹1.00 and ₹1.00 per unit.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹1.00 | 0.14% |
| 2025-March | ₹1.00 | 0.13% |
| 2024-March | ₹1.00 | 0.14% |
| 2023-March | ₹1.00 | 0.24% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Fortis Healthcare Stock Index Membership - Nifty & Sensex
See which indices include Fortis Healthcare stock. Check FORTIS index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
The company is listed in 23 indices, including BSE 1000.
Among the benchmarks tracked are BSE 1000, BSE INDEX BSE HC, BSE INDEX BSE500, BSE INDEX LMI250.
Complete Index List
Fortis Healthcare Market Events Screener - Corporate Actions
Get Fortis Healthcare corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Fortis Healthcare stock events that may affect FORTIS share price, along with derivatives, futures and options activity and sector gainers.
15 corporate actions are listed, the most recent entry being Annual General Meeting dated August 11, 2026, with a record date of August 11, 2026.
It is followed by Quarterly Result Announcement dated August 6, 2026 and Dividend dated July 24, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-08-11 | 2026-08-11 | Annual General Meeting | NA | -0.84% |
| 2026-08-06 | 2026-08-06 | Quarterly Result Announcement | NA | -2.91% |
| 2026-07-24 | 2026-07-24 | Dividend | ₹ 1.00 /share | -2.42% |
| 2026-05-22 | 2026-05-22 | Quarterly Result Announcement | NA | -0.35% |
| 2026-02-13 | 2026-02-13 | Quarterly Result Announcement | NA | 8.31% |
| 2025-11-11 | 2025-11-11 | Quarterly Result Announcement | NA | -3.69% |
| 2025-08-11 | 2025-08-11 | Annual General Meeting | NA | 16.03% |
| 2025-08-06 | 2025-08-06 | Quarterly Result Announcement | NA | 2.10% |
| 2025-07-25 | 2025-07-25 | Dividend | ₹ 1.00 /share | 23.43% |
| 2025-05-20 | 2025-05-20 | Quarterly Result Announcement | NA | 0.45% |
| 2025-02-07 | 2025-02-07 | Quarterly Result Announcement | NA | 12.06% |
| 2024-11-08 | 2024-11-08 | Quarterly Result Announcement | NA | 3.57% |
| 2024-08-02 | 2024-08-02 | Annual General Meeting | NA | 7.10% |
| 2024-07-24 | 2024-07-24 | Dividend | ₹ 1.00 /share | 3.82% |
| 2023-07-20 | 2023-07-20 | Dividend | ₹ 1.00 /share | 13.73% |
Fortis Healthcare Competitors Screener - Peer Stocks Comparison
Screen FORTIS competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare Services sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Apollo Hospitals | 110,714 | 52.28 | 25,420 | 15.58% | 2,003 | 33.23 |
| Max Healthcare Institute | 80,785 | 56.45 | 8,536 | 18.82% | 1,442 | 22.55 |
| Aster DM Quality Care | 58,154 | 161.97 | 4,769 | 11.25% | 427 | 33.60 |
| Fortis Healthcare | 55,701 | 51.99 | 9,179 | 16.93% | 1,064 | 27.41 |
| Narayana Hrudayalaya | 35,577 | 43.01 | 7,996 | 43.43% | 811 | 43.09 |
| Global Health | 33,289 | 60.41 | 4,509 | 19.56% | 554 | 28.83 |
| Krishna Institute of Medical Sciences | 28,497 | 148.08 | 3,931 | 28.16% | 242 | 28.92 |
| Dr. Agarwal's Health Care | 14,846 | 79.79 | 2,125 | 20.92% | 168 | 38.40 |
| Rainbow Childrens Medicare | 12,554 | 43.62 | 1,747 | 11.49% | 282 | 32.00 |
| Park Medi World | 9,842 | 34.36 | 1,711 | 19.99% | 274 | 26.59 |
Fortis Healthcare Company Announcements - News & Reports Screener
Screen FORTIS latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated October 19, 2026.
The next most recent announcements are dated October 18, 2026 and October 18, 2026.
| Date | Update | Actions |
|---|---|---|
| 2026-10-19 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-10-18 | To Invest In Special Purpose Vehicle (SPV) Under A Captive Solar Power Generation Project In The State Of Haryana | - |
| 2026-10-18 | Compliances-Half Yearly Report (SEBI Circular No. CIR/IMD/DF-1/67/2017) | - |
| 2026-09-29 | Announcement / Press Release Filed By IHH Healthcare Berhad (IHH) | - |
| 2026-09-27 | Update On Special Leave Petition (SLP) Filed By The Company Before The Honble Supreme Court Of India | - |
| 2026-09-25 | Closure of Trading Window | - |
| 2026-09-25 | Update On Material Litigation Filed By Northern TK Venture Pte Ltd. (NTK) The Promoter Shareholder Of The Company Against Daiichi Sankyo Company Limited Before The Tokyo District Court In Japan | - |
| 2026-09-16 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-09-16 | Intimation For Signing The Definitive Agreements By Fortis Hospotel Limited (Wholly Owned Subsidiary Of The Company) To Provide Healthcare Services To A 400+ Bedded Super Specialty Hospital In Ashok Vihar New Delhi | - |
| 2026-09-16 | Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 About Filing Of Special Leave Petition (SLP) Before The HonBle Supreme Court Of India | - |
| 2026-09-15 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-09-15 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-09-11 | Update On Material Litigation Filed By Northern TK Venture Pte Ltd. (NTK) The Promoter Shareholder Of The Company Against Daiichi Sankyo Company Limited Before The Tokyo District Court In Japan. | - |
| 2026-09-10 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-09-09 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-09-09 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-09-09 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-09-09 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-09-04 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-09-01 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹712.90, within a 52-week range of ₹712.90 to ₹1,057.00. The P/E ratio is 51.99 and the P/B ratio is 5.62, with earnings per unit of ₹13.80. Market capitalisation stands at ₹55,700.81 Cr and the dividend yield is 0.14%. The company operates in the Healthcare Services sector, in the Hospitals industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 25, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.